Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - TOTAL OTHER INCOME
Total Other Income RARE - Ultragenyx Pharmaceutical Inc.
-39.3 M
LAST VALUE
25.77%
2 YEAR CAGR
-4.15%
5 YEAR CAGR
-30.27%
10 YEAR CAGR